机译:新型非甾体醇孕酮受体(PR)拮抗剂与菲尼酮骨骼骨架
Institute of Molecular and Cellular Biosciences The University of Tokyo;
Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University;
Nihon University School of Medicine;
Institute of Molecular and Cellular Biosciences The University of Tokyo;
Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University;
Institute of Molecular and Cellular Biosciences The University of Tokyo;
Institute of Molecular and Cellular Biosciences The University of Tokyo;
antagonist; nonsteroid; phenanthridinone; Progesterone receptor;
机译:新型非甾体醇孕酮受体(PR)拮抗剂与菲尼酮骨骼骨架
机译:非甾体孕酮受体拮抗剂4-(3-环丙基-1-(甲磺甲基)-5-甲基-1H-吡唑-4-基)氧基,-2,6-二甲基苯甲腈(PF-02413873)的翻译功效,猕猴和人子宫内膜的生长
机译:PF-02413873(一种非甾体孕激素受体拮抗剂)的临床前和临床药代动力学。
机译:在受控卵巢过度刺激手术中HCG给药当天的高孕酮水平降低了胚胎麦卡纳涅什蒂纳内膜中黄体酮受体的表达
机译:糖皮质激素受体和孕激素受体对叶酸受体-α的调节。
机译:新型非甾体孕酮受体(PR)拮抗剂与菲蒽酮骨架
机译:作为新型非甾体醇酮受体拮抗剂的N-(4-苯氧基苯基)苯磺胺酰胺衍生物的研制
机译:激动剂和拮抗剂占据孕酮受体调节靶基因的机制